<DOC>
	<DOCNO>NCT00523601</DOCNO>
	<brief_summary>To reassure clinical study data Seroquel antidepressant efficacy patient diagnose bipolar depression</brief_summary>
	<brief_title>Quetiapine Efficacy Bipolar Depression Study</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>The patient patient 's legal representative ( ) must understand nature study must give write consent Meet DSMIVTR criterion bipolar depression time baseline Since programme intend describe quetiapine use routine clinical practice prescribe treatment bipolar depression , programme specific exclusion criterion , : Or , follow regarded criterion exclusion programme : 1 . Serious unstable , medical illness . Subjects chronic illness may include must stable otherwise physically healthy basis physical examination , medical history 2 . Known intolerance lack response quetiapine , judge investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>Bipolar depression</keyword>
	<keyword>quetiapine</keyword>
	<keyword>observational</keyword>
	<keyword>Naturalistic</keyword>
</DOC>